DSGN
#2571
Design Therapeutics, Inc. - Common Stock
13.5 2 USD
-0.01%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-1.37%
Monthly Change
+21.36%
6 month change
+43.98%
Year Change
+226.57%
Previous Close
13.6 7
Open
13.6 2
Low
13.4 8
High
13.6 2
Volume
10
Financials
- Market Capitalization 844.42 M
- Employee 54
- Founded 2017
- CEO N/A
- Website www.designtx.com
- Headquarter Delaware, United States
- FIGI BBG00SNC49V8
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 2554 |  PHAT Phathom Pharmaceuticals, Inc. - Common Stock | 11.04 USD | +1.10% | -3.83% | +3.08% | +27.63% | 880.51 M USD | ||
| 2562 |  TBPH Theravance Biopharma, Inc. - Ordinary Shares | 16.92 USD | +0.12% | -0.53% | +3.05% | +17.91% | 872.28 M USD | ||
| 2573 |  IVA Inventiva S.A. - American Depository Shares | 4.47 USD | +1.59% | -2.19% | +19.84% | +35.87% | 863.77 M USD | ||
| 2597 |  REPL Replimune Group, Inc. - Common Stock | 9.87 USD | -0.70% | -14.02% | +10.90% | -25.17% | 828.54 M USD |
Frequently asked questions about Design Therapeutics, Inc. - Common Stock
What is the Design Therapeutics, Inc. - Common Stock stock price today?
The current price of Design Therapeutics, Inc. - Common Stock (DSGN) is 13.52. Over the past 24 hours, the stock has changed by -1.37%. Follow the DSGN chart for real-time price dynamics.
What is the stock ticker of Design Therapeutics, Inc. - Common Stock?
Design Therapeutics, Inc. - Common Stock trades under the ticker DSGN. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Design Therapeutics, Inc. - Common Stock stock going up?
DSGN has changed by -10.11% over the last week, +21.36% over the last month, and +226.57% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Design Therapeutics, Inc. - Common Stock net income for the last quarter?
Design Therapeutics, Inc. - Common Stock reported net income of -17.64 M for the last quarter. The previous quarter showed -16 M, which means net income changed by -10.25%.
How many employees does Design Therapeutics, Inc. - Common Stock have?
As of the latest available data, Design Therapeutics, Inc. - Common Stock has 54 employees. Workforce size can provide additional context about the company's scale and operations.
How can I buy Design Therapeutics, Inc. - Common Stock stock?
You can buy Design Therapeutics, Inc. - Common Stock (DSGN) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Design Therapeutics, Inc. - Common Stock stock?
Investing in Design Therapeutics, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the DSGN chart and related analysis on metatrader.com as part of your research.